Blog

How Quantitative Systems Pharmacology Addresses Key Challenges in Alzheimer’s Drug Development

Quantitative Systems Pharmacology (QSP) helps address key challenges in Alzheimer’s disease drug development, including tau…

Certara2026 年 2 月 2 日

On-Demand Webinar

Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy

Watch this on-demand webinar to learn how model-based meta-analysis (MBMA), quantitative systems pharmacology (QSP), and…

Certara2026 年 1 月 22 日

On-Demand Webinar

安全第一：揭示化合物筛选数据中的临床风险

Learn how to interpret screening assay data to predict clinical off-target risk with ToxStudio® and…

Certara2026 年 1 月 13 日

Guide Infographic

新方法学（NAMs）：数据视角

We outline today’s animal-use landscape, the rise of NAMs, & how the Non-Animal Navigator supports…

Certara2025 年 12 月 10 日

Podcast Press Coverage

新方法学：重新定义动物实验替代方案

Explore how New Approach Methodologies (NAMs) and advanced in silico and in vitro tools are…

Certara2025 年 12 月 10 日

Guide

关于 FDA 宣布逐步淘汰药物动物实验的指南

FDA 正在逐步淘汰新药的动物实验。Learn how Certara’s Non-Animal Navigator™…

Certara2025 年 11 月 17 日

Announcement

Certara 一项研究显示，半数美国人不知道 FDA 和 NIH 正计划逐步淘汰新药的动物实验

Certara’s new survey findings show that 50% of Americans are unaware of FDA and NIH…

Certara2025 年 11 月 12 日

Publication

Towards new approach methodologies for biological therapeutics: a novel model-informed metric to assess immunogenicity risk

Immunogenicity poses a significant challenge in biotherapeutics development due to the formation of anti-drug antibodies…

Danielle Pillsbury2025 年 11 月 7 日

On-Demand Webinar

In silico Safety and Toxicology assessment: ToxStudio®

Discover how Certara’s ToxStudio align with FDA’s roadmap to reduce animal testing and transform preclinical…

Certara2025 年 10 月 30 日

Press Coverage

Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research

The article, "Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research," explores a…

Danielle Pillsbury2025 年 9 月 10 日

New Approach Methodologies (NAMs)

How Quantitative Systems Pharmacology Addresses Key Challenges in Alzheimer’s Drug Development

Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy

安全第一：揭示化合物筛选数据中的临床风险

新方法学（NAMs）：数据视角

新方法学：重新定义动物实验替代方案

关于 FDA 宣布逐步淘汰药物动物实验的指南

Certara 一项研究显示，半数美国人不知道 FDA 和 NIH 正计划逐步淘汰新药的动物实验

Towards new approach methodologies for biological therapeutics: a novel model-informed metric to assess immunogenicity risk

In silico Safety and Toxicology assessment: ToxStudio®

Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research

订阅时事通讯

快捷链接

解决方案

联系我们